Rosenblatt Reiterates Buy on Imax, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel has reiterated a Buy rating on Imax Corporation (NYSE:IMAX) and maintained a $30 price target for the company's stock.
December 05, 2023 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel reaffirmed a Buy rating on Imax Corporation with a $30 price target, indicating a positive outlook for the stock.
The reiteration of a Buy rating and maintenance of a $30 price target by a Rosenblatt analyst suggests a positive sentiment towards Imax's stock. This could influence investors to maintain or establish positions in IMAX, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100